Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
30.44
+0.38 (1.26%)
Jan 16, 2026, 4:00 PM EST - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $503.04 million as of January 16, 2026. Its market cap has increased by 110.47% in one year.
Market Cap
503.04M
Enterprise Value
5.12B
1-Year Change
110.47%
Ranking
Category
Stock Price
$30.44
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $503.04M, an increase of 107.01%. That is a compound annual growth rate of 13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 503.04M | -28.80% |
| Dec 31, 2025 | 706.47M | 195.58% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |